The OR may feel the savings before the spreadsheet can prove them.
Christopher E. Pelt, MD, points out a common disconnect: hospitals may not know how to assign real cost to SPD time, tray burden, employee overtime, and case volume. His point is that operational efficiency can be obvious in the room even when finance has not built the right box for it yet.
From the Total Joint Orthopedics Masterclass.
Watch the full video: https://t.co/O49G2uTDCY
@akinbomd@jointdocShields@generalorthomd Don’t leave it unresurfaced. That’s how I was trained. Watched patella’s fracture and melt away. Just put a button back on it. https://t.co/3DMwQQxkyE
Apply by June 1st for the annual Aaron A. Hofmann Resident Award. The winner will receive $1,000, the opportunity to present their abstract on the podium at PCHK, and an invite to the Faculty dinner.
Submit your application: https://t.co/pFYAzagrVg
@PeltMD@M_BolognesiMD
Liftoff.
The Artemis II mission launched from @NASAKennedy at 6:35pm ET (2235 UTC), propelling four astronauts on a journey around the Moon.
Artemis II will pave the way for future Moon landings, as well as the next giant leap — astronauts on Mars.
@jointdocShields@RealPhysician Alone, I would agree. But as a part of a multimodal protocol, it seems to have unlocked a new dimension. Tylenol, anti-inflammatory, a neuro modulator in those that tolerate, and suzetrgine. All scheduled. Opioid for break through. A 5 prong approach to pain. We are closer now.
@jointdocShields@RealPhysician Have incorporated suzetrigine to our multimodal pain protocol. Has been a game changer. We d/c TKAs with 8 oxycodone for breakthrough pain. Many patients I see back at their 6 week say they aren't even using that many.
@prem_ramkumar@JArthroplasty wearing these vests also increased my physiologic demands. lol. fun study, but I wish we could just wear watches in the OR.
We’re excited to share that the 2026 PCHK Symposium will take place at a brand-new venue: the Grand Hyatt Deer Valley.
An ideal meeting for meaningful connections and educational exchange, the Symposium is set for August 13–15.
Registration is now open!
https://t.co/YWP28crqWa
@ArthroToday@sbinimd@jmaratt@EdinburghKnee The patella really doesn’t like to be told what to do. The trochlear groove allowing the patella to track where it wants, is a very good thing.
Difficult bacteria to treat. No good oral antibiotics other than Linezolid which has cost and toxicity issues. Unique resistance patterns can occur with Corynebacterium as well.
Corynebacterium-associated PJIs represent a unique subset of disease that can be challenging to manage, but with close collaboration between surgical and infectious disease teams, reasonable outcomes can be expected.
https://t.co/BIANEJ57d8
@ArthroToday Have seen some downsides to this technique as well. Limited soft tissue over this area and the cortical window allowing for drainage can make for issues with drainage, sinus formation and PJI. It works to extract the implant. But beware of the closure.
@JArthroplasty Consolidation drives reduced market competition, increases in hospital pricing, increase in supplies and reduced access to patients. Hospitals gain higher facility reimbursements. Higher costs passed on to insurance and pts is passed on to insurance (raised premiums) and pts.
@JArthroplasty It's important to continue to highlight the impacts of consolidation to the patient and on the healthcare system. CMS thinks they are saving money by paying surgeons less, surgeons aren't the expensive part of healthcare.
Healthcare consolidation has major effects: increased costs, reduced access, declines in care quality, and a loss of physician autonomy. Arthroplasty surgeons risk losing control over decision-making and access to high-quality, efficient healthcare.
https://t.co/dTACuBLAJn